Meetings/Upcoming events

[ If you wish to add a meeting, send us details using 'Contact' form ]

• Cell Death Gordon Research Conference
  August 5-10, 2018, Sunday River, Newry, ME, USA
  The Conference Chair is currently developing a meeting description. This information will be available by September 1, 2017. Please check back for updates.
  
  
• The 11th European Workshop on Cell Death
  May 6-11, 2018, Fiuggi, Italy
  The upcoming workshop will focus on basic as well as translational research into cell death, inflammation and cancer. In the past, work presented these workshops has aided in targeting cell death pathways for disease such as cancer, and we are confident that the EWCD meetings will continue to be an excellent platform for the exchange of innovative ideas and cutting-edge science.
  
  
• A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments
  February 1-3, 2018, Amsterdam, Netherlands
  Evading cell death is a hallmark of cancer cells, which contributes to tumour growth and therapeutic resistance. But cancer cells also highjack mechanisms like protective autophagy or senescence to promote tumour growth. Cell death is an important determinant of the immune response to cancer, which may either increase the antitumour effect or promote tumour growth.
  The conference will cover exciting new insights into this highly-relevant field, so please join us in Amsterdam to be stimulated by the latest research updates!
  
  
• Cell Death, Inflammation and Adaptation to Tissue Stress (A6)
  January 21-25, 2018, Beaver Run Resort, Breckenridge, Colorado, USA
  Cell death and inflammation are ancient processes of fundamental biological importance in both normal physiology and human disease pathologies. The recent observation that cell death regulatory components have dual roles in cell death and inflammation suggests that these proteins function not primarily to kill, but to coordinate tissue repair and adaptation to tissue stress. This perspective unifies cell death components as positive regulators of tissue repair that replace malfunctioning or damaged tissues and enhances the resilience of epithelia to insult. It is now recognized that cells that die do not do so silently, but release a variety of paracrine signals to communicate with their cellular environment to ensure tissue regeneration and wound healing. Moreover, inflammatory signaling pathways, such as those emanating from the TNF-receptor or Toll-related receptors, take part in cell competition to eliminate developmentally aberrant clones. Understanding how dead and dying cells initiate and escalate inflammation has important implications for the development of novel treatment strategies for diseases associated with aging, such as chronic inflammation and cancer. This conference explores the complex relationship between cell death and inflammation, and how this cross-talk impacts on adaptation to tissue stress, inflammatory diseases, tumor formation and drug resistance. Overall, the goals of the conference are to: 1) Explore the gaps in our current understanding of how dead and dying cells influence inflammatory responses in tissue repair and disease settings; 2) Foster communication and collaborations between scientists focusing on different areas of biology (cell death, innate immunity, adaptive immunity, cancer and model organisms); 3) Pinpoint nodes of intersection linking all research fields; 4) Define key-regulatory paradigms at these intersections, and discuss molecular mechanisms that control these processes; 5) Share information on possible consequences of deregulation; 6) Discuss translational aspects and potential drug targets, e.g. in pre-clinical models of malignant disease.
  
  
• 25th Conference of the European Cell Death Organization
  September 27-29, 2017, Leuven, Belgium
  The 25th ECDO Conference will be dedicated to one of the hottest topic in biomedical and cell death research; the intersection between cell death and the immune system, which is central to physiological healing responses, key human pathologies and the development of novel therapeutics.